Pacer Advisors Inc. Buys 47,745 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Pacer Advisors Inc. raised its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 8.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 592,001 shares of the company’s stock after acquiring an additional 47,745 shares during the period. Pacer Advisors Inc.’s holdings in USANA Health Sciences were worth $21,247,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of USNA. Safe Harbor Fiduciary LLC bought a new position in USANA Health Sciences in the third quarter valued at approximately $30,000. KBC Group NV increased its stake in shares of USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares during the last quarter. Centiva Capital LP acquired a new position in shares of USANA Health Sciences during the 3rd quarter worth $213,000. Quest Partners LLC bought a new stake in shares of USANA Health Sciences during the 3rd quarter worth $250,000. Finally, Exchange Traded Concepts LLC boosted its stake in USANA Health Sciences by 4.4% in the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after buying an additional 322 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have commented on USNA. DA Davidson boosted their target price on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research note on Thursday, January 2nd. StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 28th.

USANA Health Sciences Stock Down 0.1 %

Shares of USNA opened at $34.35 on Wednesday. The stock has a market cap of $654.71 million, a PE ratio of 12.14, a PEG ratio of 0.92 and a beta of 0.89. USANA Health Sciences, Inc. has a 12-month low of $31.44 and a 12-month high of $52.75. The business has a 50-day simple moving average of $36.23 and a two-hundred day simple moving average of $38.26.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.